Amylyx Pharmaceuticals
AMLX
AMLX
131 hedge funds and large institutions have $524M invested in Amylyx Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 37 increasing their positions, 37 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 37
3% less funds holding
Funds holding: 135 → 131 (-4)
11% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 36
Holders
131
Holding in Top 10
6
Calls
$1.48M
Puts
$103K
Top Buyers
| 1 | +$17.6M | |
| 2 | +$15.2M | |
| 3 | +$15.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.19M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$6.15M |
Top Sellers
| 1 | -$8.23M | |
| 2 | -$7.64M | |
| 3 | -$7.37M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.62M |
| 5 |
Goldman Sachs
New York
|
-$3.43M |